FDA inspection
C2C Development, LLC: FDA inspection ending Aug 3, 2023
FDA inspection 1213026 · No Action Indicated (NAI) · Melbourne, FL
Key facts
| Inspection ID | 1213026 |
|---|---|
| Firm | C2C Development, LLC |
| FEI number | 3011193444 |
| Address | 1135 W Nasa Blvd Ste 500 |
| City | Melbourne |
| State | FL |
| ZIP | 32901 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Aug 3, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data